BLLN
BillionToOne, Inc. Class A Common Stock
NASDAQ: BLLN · HEALTHCARE · DIAGNOSTICS & RESEARCH
$75.05
+1.82% today
Updated 2026-04-30
Market cap
$3.90B
P/E ratio
605.29
P/S ratio
12.77x
EPS (TTM)
$0.14
Dividend yield
—
52W range
$62 – $139
Volume
0.4M
BillionToOne, Inc. Class A Common Stock (BLLN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $71.73M | $152.58M | $305.11M |
| Revenue growth (YoY) | — | +112.7% | +100.0% |
| Cost of revenue | $54.42M | $71.67M | $96.65M |
| Gross profit | $17.31M | $80.92M | $208.46M |
| Gross margin | 24.1% | 53.0% | 68.3% |
| R&D | $22.41M | $36.60M | $49.38M |
| SG&A | — | — | $143.05M |
| Operating income | $-69.50M | $-47.15M | $16.02M |
| Operating margin | -96.9% | -30.9% | 5.3% |
| EBITDA | $-72.94M | $-27.47M | $16.02M |
| EBITDA margin | -101.7% | -18.0% | 5.3% |
| EBIT | $-79.40M | $-39.16M | — |
| Interest expense | $3.27M | $2.39M | $95000.00 |
| Income tax | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% |
| Net income | $-82.68M | $-41.57M | $7.45M |
| Net income growth (YoY) | — | +49.7% | +117.9% |
| Profit margin | -115.3% | -27.2% | 2.4% |